Gene L Bowman

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. pmc Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease
    Gene L Bowman
    Department of Neurology, Oregon Health and Science University, 3181 Southwest Samuel Jackson Park Road, Portland, OR 97239, USA
    Curr Gerontol Geriatr Res 2012:184042. 2012
  2. pmc Ascorbic acid, cognitive function, and Alzheimer's disease: a current review and future direction
    Gene L Bowman
    Department of Neurology, CR 131, Oregon Health and Science University, Portland, OR, USA
    Biofactors 38:114-22. 2012
  3. pmc Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging
    G L Bowman
    Department of Neurology, Oregon Health and Science University, Portland, USA
    Neurology 78:241-9. 2012
  4. pmc Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment
    Gene L Bowman
    Department of Neurology, Oregon Health and Science University, Portland, OR 97239, USA
    Alzheimer Dis Assoc Disord 25:49-57. 2011
  5. pmc Uric acid as a CNS antioxidant
    Gene L Bowman
    Department of Neurology, Layton Center for Aging and Alzheimer s Disease Research, Oregon Health and Science University, Portland, OR 97239, USA
    J Alzheimers Dis 19:1331-6. 2010
  6. pmc Ascorbic acid and rates of cognitive decline in Alzheimer's disease
    Gene L Bowman
    Department of Neurology, Oregon Health and Science University, Portland, OR, USA
    J Alzheimers Dis 16:93-8. 2009
  7. pmc Blood-brain barrier impairment in Alzheimer disease: stability and functional significance
    G L Bowman
    Department of Neurology, Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USA
    Neurology 68:1809-14. 2007
  8. pmc Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study
    Hiroko H Dodge
    Department of Neurology, Oregon Health and Science University, Portland, OR 97239 3098, USA
    J Gerontol A Biol Sci Med Sci 65:1060-7. 2010
  9. doi request reprint Memory, mood, and vitamin d in persons with Parkinson's disease
    Amie L Peterson
    Parkinson s Disease Research, Education and Clinical Center PADRECC, Portland VA Medical Center, Portland, OR, USA Oregon Health and Science University, Portland, OR, USA
    J Parkinsons Dis 3:547-55. 2013

Detail Information

Publications10

  1. pmc Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease
    Gene L Bowman
    Department of Neurology, Oregon Health and Science University, 3181 Southwest Samuel Jackson Park Road, Portland, OR 97239, USA
    Curr Gerontol Geriatr Res 2012:184042. 2012
    ..Conclusion. Dyslipidemia is more prevalent in AD subjects with BBB impairment. Plasma triglyceride and HDL cholesterol may have a role in maintaining BBB integrity in mild-to-moderate Alzheimer's disease...
  2. pmc Ascorbic acid, cognitive function, and Alzheimer's disease: a current review and future direction
    Gene L Bowman
    Department of Neurology, CR 131, Oregon Health and Science University, Portland, OR, USA
    Biofactors 38:114-22. 2012
    ..A final synopsis highlights areas for future research regarding AA nourishment and healthy brain aging...
  3. pmc Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging
    G L Bowman
    Department of Neurology, Oregon Health and Science University, Portland, USA
    Neurology 78:241-9. 2012
    ..To examine the cross-sectional relationship between nutrient status and psychometric and imaging indices of brain health in dementia-free elders...
  4. pmc Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment
    Gene L Bowman
    Department of Neurology, Oregon Health and Science University, Portland, OR 97239, USA
    Alzheimer Dis Assoc Disord 25:49-57. 2011
    ..Our study objective was to examine the reliability and validity of the 2 common nutritional assessments (plasma nutrient biomarkers and Food Frequency Questionnaire) in the people at risk for dementia...
  5. pmc Uric acid as a CNS antioxidant
    Gene L Bowman
    Department of Neurology, Layton Center for Aging and Alzheimer s Disease Research, Oregon Health and Science University, Portland, OR 97239, USA
    J Alzheimers Dis 19:1331-6. 2010
    ..Adequately powered prospective studies would help assess any role for UA in primary and secondary prevention of AD...
  6. pmc Ascorbic acid and rates of cognitive decline in Alzheimer's disease
    Gene L Bowman
    Department of Neurology, Oregon Health and Science University, Portland, OR, USA
    J Alzheimers Dis 16:93-8. 2009
    ..This relationship may indicate that the CSF: plasma AA ratio is an index of AA availability to the brain or may be an artifact of a relationship between blood-brain barrier impairment and neurodegeneration...
  7. pmc Blood-brain barrier impairment in Alzheimer disease: stability and functional significance
    G L Bowman
    Department of Neurology, Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USA
    Neurology 68:1809-14. 2007
    ..To determine the stability and functional significance of blood-brain barrier (BBB) integrity in patients with mild to moderate Alzheimer disease (AD)...
  8. pmc Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study
    Hiroko H Dodge
    Department of Neurology, Oregon Health and Science University, Portland, OR 97239 3098, USA
    J Gerontol A Biol Sci Med Sci 65:1060-7. 2010
    ....
  9. doi request reprint Memory, mood, and vitamin d in persons with Parkinson's disease
    Amie L Peterson
    Parkinson s Disease Research, Education and Clinical Center PADRECC, Portland VA Medical Center, Portland, OR, USA Oregon Health and Science University, Portland, OR, USA
    J Parkinsons Dis 3:547-55. 2013
    ..Objective: To examine the relationship between serum vitamin D and neuropsychiatric function in persons with Parkinson's disease (PD)...